IL1RN and KRT13 Expression in Bladder Cancer: Association with Pathologic Characteristics and Smoking Status

by Thomas S. Worst, Verena Reiner, Ute Gabriel, Christel Weiß, Philipp Erben, Thomas Martini, Christian Bolenz
Published 2014-01-01

Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer

by Sebastien Rinaldetti, Thomas Stefan Worst, Eugen Rempel, Maximilian C. Kriegmair, Arndt Hartmann, Stefan Porubsky, Christian Bolenz, Philipp Erben
Published 2020-11-01

<i>ANLN</i> and <i>TLE2</i> in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data

by Sheng Wu, Katja Nitschke, Jakob Heinkele, Cleo-Aron Weis, Thomas Stefan Worst, Markus Eckstein, Stefan Porubsky, Philipp Erben
Published 2019-11-01

Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer

by Sheng Wu, Katja Nitschke, Thomas Stefan Worst, Alexander Fierek, Cleo-Aron Weis, Markus Eckstein, Stefan Porubsky, Maximilian Kriegmair, Philipp Erben
Published 2020-12-01

The EEF1A2 gene expression as risk predictor in localized prostate cancer

by Thomas Stefan Worst, Frank Waldbillig, Abdallah Abdelhadi, Cleo-Aron Weis, Maria Gottschalt, Annette Steidler, Jost von Hardenberg, Maurice Stephan Michel, Philipp Erben
Published 2017-09-01

RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based Chemotherapy

by Jonas Herrmann, Helena Schmidt, Katja Nitschke, Cleo-Aron Weis, Philipp Nuhn, Jost von Hardenberg, Maurice Stephan Michel, Philipp Erben, Thomas Stefan Worst
Published 2021-04-01

The Impact of Small Extracellular Vesicles on Lymphoblast Trafficking across the Blood-Cerebrospinal Fluid Barrier In Vitro

by Ulrike Erb, Julia Hikel, Svenja Meyer, Hiroshi Ishikawa, Thomas S. Worst, Katja Nitschke, Philipp Nuhn, Stefan Porubsky, Christel Weiss, Horst Schroten, Rüdiger Adam, Michael Karremann
Published 2020-07-01

Phosphodiesterase <i>SMPDL3B</i> Gene Expression as Independent Outcome Prediction Marker in Localized Prostate Cancer

by Frank Waldbillig, Katja Nitschke, Abdallah Abdelhadi, Jost von Hardenberg, Philipp Nuhn, Malin Nientiedt, Cleo-Aron Weis, Maurice Stephan Michel, Philipp Erben, Thomas Stefan Worst
Published 2020-06-01

Neutral sphingomyelinases control extracellular vesicles budding from the plasma membrane

by Kerstin Menck, Can Sönmezer, Thomas Stefan Worst, Matthias Schulz, Gry Helene Dihazi, Frank Streit, Gerrit Erdmann, Simon Kling, Michael Boutros, Claudia Binder, Julia Christina Gross
Published 2017-12-01

FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy

by Danijel Sikic, Markus Eckstein, Ralph M. Wirtz, Jonas Jarczyk, Thomas S. Worst, Stefan Porubsky, Bastian Keck, Frank Kunath, Veronika Weyerer, Johannes Breyer, Wolfgang Otto, Sebastien Rinaldetti, Christian Bolenz, Arndt Hartmann, Bernd Wullich, Philipp Erben
Published 2020-04-01

Contemporary Outcomes after Transurethral Procedures for Bladder Neck Contracture Following Endoscopic Treatment of Benign Prostatic Hyperplasia

by Clemens M. Rosenbaum, Malte W. Vetterlein, Margit Fisch, Philipp Reiss, Thomas Stefan Worst, Jennifer Kranz, Joachim Steffens, Luis A. Kluth, Daniel Pfalzgraf, on behalf of the Trauma and Reconstructive Urology Working Party of the European Association of Urology (EAU) Young Academic Urologists (YAU)
Published 2021-06-01